Iterum Therapeutics Presented Data at the 32nd European Congress of Clinical Microbiology and Infectious Diseases Apr 25, 2022
Iterum Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2021 Financial Results on March 28, 2022 Mar 21, 2022
Iterum Therapeutics Granted 180-Day Extension by Nasdaq to Regain Compliance with Bid Price Rule Mar 10, 2022
Iterum Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Update Nov 12, 2021
